Bio-Techne Corporation (FRA:TE1)
Germany · Delayed Price · Currency is EUR 57.00
+0.50 (0.88%)
Last updated: Jan 28, 2026, 8:02 AM CET
Bio-Techne Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 77.99 | 73.4 | 168.11 | 285.44 | 272.05 | 140.41 |
Depreciation & Amortization | 62.11 | 65.9 | 65.11 | 62.94 | 60.47 | 51.25 |
Other Amortization | 44 | 44 | 46.6 | 44.3 | 40.6 | 36.5 |
Loss (Gain) From Sale of Assets | 73.71 | 80.5 | 21.96 | -11.68 | - | - |
Asset Writedown & Restructuring Costs | 15.27 | 21.31 | 2.63 | - | 19.26 | - |
Loss (Gain) From Sale of Investments | -2.05 | - | - | -37.18 | -15 | 67.88 |
Loss (Gain) on Equity Investments | -0.86 | -0.94 | 6.84 | 1.14 | - | - |
Stock-Based Compensation | 42.33 | 40.83 | 38.04 | 39.23 | 42.18 | 48.98 |
Other Operating Activities | -39.67 | -49 | -40.21 | -39.23 | -24.77 | -22.12 |
Change in Accounts Receivable | 34.96 | 34.13 | -20.53 | -20.87 | -57.6 | -15.55 |
Change in Inventory | -29.34 | -18.14 | -14.22 | -30.17 | -32.01 | -7.14 |
Change in Accounts Payable | -5.16 | -13.95 | 25.77 | -7.91 | 12.74 | 19.09 |
Change in Income Taxes | -12.75 | 8.47 | -10.6 | -2.49 | 2.67 | 13.43 |
Change in Other Net Operating Assets | -9.28 | 1.04 | 9.47 | -29.14 | 4.68 | 19.44 |
Operating Cash Flow | 251.25 | 287.56 | 298.98 | 254.39 | 325.27 | 352.16 |
Operating Cash Flow Growth | -17.21% | -3.82% | 17.53% | -21.79% | -7.64% | 71.61% |
Capital Expenditures | -27.2 | -31.01 | -62.88 | -38.24 | -44.91 | -44.3 |
Sale of Property, Plant & Equipment | 7.06 | 2.45 | - | - | - | - |
Cash Acquisitions | - | - | -169.71 | -101.18 | - | -225.35 |
Divestitures | - | - | - | 17.82 | - | - |
Investment in Securities | 7.24 | -6.62 | 29.55 | -144.05 | -26.94 | 26.14 |
Other Investing Activities | - | - | - | - | -25 | - |
Investing Cash Flow | -12.89 | -35.18 | -203.03 | -265.65 | -96.85 | -243.52 |
Long-Term Debt Issued | - | 104 | 225 | 619.66 | 90 | 256 |
Long-Term Debt Repaid | - | -77 | -256 | -525.66 | -175.5 | -271.5 |
Net Debt Issued (Repaid) | - | 27 | -31 | 94 | -85.5 | -15.5 |
Issuance of Common Stock | 50.13 | 51.74 | 60.94 | 29.81 | 77.16 | 65.09 |
Repurchase of Common Stock | -286.52 | -282.25 | -101.91 | -48.46 | -184.41 | -62.52 |
Common Dividends Paid | -50.15 | -50.39 | -50.42 | -50.29 | -50.19 | -49.62 |
Other Financing Activities | - | - | - | -2.46 | 0.09 | - |
Financing Cash Flow | -286.54 | -253.91 | -122.4 | 22.62 | -242.85 | -62.55 |
Foreign Exchange Rate Adjustments | 5.6 | 11.93 | -2.33 | -3.36 | -12.09 | 6.37 |
Net Cash Flow | -42.58 | 10.4 | -28.78 | 8 | -26.52 | 52.47 |
Free Cash Flow | 224.06 | 256.55 | 236.1 | 216.15 | 280.36 | 307.86 |
Free Cash Flow Growth | -8.56% | 8.66% | 9.23% | -22.90% | -8.93% | 100.60% |
Free Cash Flow Margin | 18.41% | 21.04% | 20.37% | 19.02% | 25.36% | 33.07% |
Free Cash Flow Per Share | 1.41 | 1.61 | 1.47 | 1.33 | 1.71 | 1.90 |
Cash Interest Paid | 18.57 | 18.96 | 14.5 | 8.37 | 11.03 | 13.58 |
Cash Income Tax Paid | 88.68 | 74.36 | 65.25 | 88.43 | 30.34 | 20.95 |
Levered Free Cash Flow | 278.55 | 313.92 | 214.19 | 184.46 | 214.22 | 257.4 |
Unlevered Free Cash Flow | 284.34 | 319.24 | 224.02 | 191.47 | 221.29 | 266.12 |
Change in Working Capital | -21.57 | 11.54 | -10.11 | -90.58 | -69.52 | 29.26 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.